Cargando…

Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia

BACKGROUND: We investigated the serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in patients with chronic schizophrenia. METHODS: Sixty-eight patients who met the DSM-IV-TR criteria and had a chronic schizophrenia (CS) duratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimura, Reiji, Hori, Hikaru, Katsuki, Asuka, Atake, Kiyokazu, Nakamura, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712493/ https://www.ncbi.nlm.nih.gov/pubmed/26770258 http://dx.doi.org/10.1186/s12991-015-0084-9

Ejemplares similares

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
por: Atake, Kiyokazu, et al.
Publicado: (2015)

Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder
por: Atake, Kiyokazu, et al.
Publicado: (2014)

Relationships between brain-derived neurotrophic factor, clinical symptoms, and decision-making in chronic schizophrenia: data from the Iowa Gambling Task
por: Hori, Hikaru, et al.
Publicado: (2014)

The Impact of Aging, Psychotic Symptoms, Medication, and Brain-Derived Neurotrophic Factor on Cognitive Impairment in Japanese Chronic Schizophrenia Patients
por: Atake, Kiyokazu, et al.
Publicado: (2018)

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
por: Hori, Hikaru, et al.
Publicado: (2018)

BDNF, proBDNF and IGF-1 serum levels in naïve and medicated subjects with autism
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2022)

Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2012)

Association of Plasma Pro-Brain-Derived Neurotrophic Factor (proBDNF)/Mature Brain-Derived Neurotrophic Factor (mBDNF) Levels with BDNF Gene Val66Met Polymorphism in Alcohol Dependence
por: Mo, Min, et al.
Publicado: (2021)

Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Correction: Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2013)

Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depression
por: Yoshimura, Reiji, et al.
Publicado: (2022)

Serum mBDNF and ProBDNF Expression Levels as Diagnosis Clue for Early Stage Parkinson's Disease
por: Yi, Xu, et al.
Publicado: (2021)

Platelets Selectively Regulate the Release of BDNF, But Not That of Its Precursor Protein, proBDNF
por: Le Blanc, Jessica, et al.
Publicado: (2020)

Decrease in the Ratio proBDNF/BDNF in the Urine of Aging Female Patients with OAB
por: Covarrubias, Claudia, et al.
Publicado: (2023)

Rapid Increases in proBDNF after Pilocarpine-Induced Status Epilepticus in Mice Are Associated with Reduced proBDNF Cleavage Machinery123
por: Thomas, Ajay X., et al.
Publicado: (2016)

BDNF and proBDNF Serum Protein Levels in Obstructive Sleep Apnea Patients and Their Involvement in Insomnia and Depression Symptoms
por: Gabryelska, Agata, et al.
Publicado: (2022)

Plasma levels of 3-methoxy-4-hydroxyphenylglycol are associated with microstructural changes within the cerebellum in the early stage of first-episode schizophrenia: a longitudinal VBM study
por: Nishimura, Joji, et al.
Publicado: (2014)

Opposing presynaptic roles of BDNF and ProBDNF in the regulation of persistent activity in the entorhinal cortex
por: Gibon, Julien, et al.
Publicado: (2016)

Influence of Quadrato Motor Training on Salivary proNGF and proBDNF
por: Caserta, Micaela, et al.
Publicado: (2019)

Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia
por: Hori, Hikaru, et al.
Publicado: (2017)

Proteolysis of proBDNF Is a Key Regulator in the Formation of Memory
por: Barnes, Philip, et al.
Publicado: (2008)

proBDNF inhibits the proliferation and migration of OLN-93 oligodendrocytes
por: Liu, Shen, et al.
Publicado: (2018)

ProBDNF as an Indicator of Improvement among Women with Depressive Episodes
por: Zwolińska, Weronika, et al.
Publicado: (2022)

Serum Brain-Derived Neurotrophic Factor, and Plasma Catecholamine Metabolites in People with Major Depression: Preliminary Cross-Sectional Study
por: Yoshimura, Reiji, et al.
Publicado: (2018)

Proteolytic cleavage of proBDNF into mature BDNF in the basolateral amygdala is necessary for defeat-induced social avoidance
por: Dulka, Brooke N., et al.
Publicado: (2016)

Role of BDNF/ProBDNF Imbalance in Postoperative Cognitive Dysfunction by Modulating Synaptic Plasticity in Aged Mice
por: Xue, Ziyi, et al.
Publicado: (2022)

Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder
por: Yoshimura, Reiji, et al.
Publicado: (2017)

Risk factors for further sick leave among Japanese workers returning to work after an episode of major depressive disorder: a prospective follow-up study over 1 year
por: Hori, Hikaru, et al.
Publicado: (2019)

Increased Hippocampal ProBDNF Contributes to Memory Impairments in Aged Mice
por: Buhusi, Mona, et al.
Publicado: (2017)

Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain–liver axis
por: Yang, B, et al.
Publicado: (2017)

Acute stress alters transcript expression pattern and reduces processing of proBDNF to mature BDNF in Dicentrarchus labrax
por: Tognoli, Chiara, et al.
Publicado: (2010)

Evaluation of HIF-1 Involvement in the BDNF and ProBDNF Signaling Pathways among Obstructive Sleep Apnea Patients
por: Gabryelska, Agata, et al.
Publicado: (2022)

Changes in Plasma TPH2, GDNF, Trk-b, BDNF, and proBDNF in People Who Died by Suicide
por: Liu, Xiaoyu, et al.
Publicado: (2023)

Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF)
por: Kailainathan, Sumangali, et al.
Publicado: (2016)

HBpF-proBDNF: A New Tool for the Analysis of Pro-Brain Derived Neurotrophic Factor Receptor Signaling and Cell Biology
por: Gaub, Perrine, et al.
Publicado: (2016)

ProBDNF Collapses Neurite Outgrowth of Primary Neurons by Activating RhoA
por: Sun, Ying, et al.
Publicado: (2012)

Requirements of Postnatal proBDNF in the Hippocampus for Spatial Memory Consolidation and Neural Function
por: Sun, Wei, et al.
Publicado: (2021)

ProBDNF and Brain-Derived Neurotrophic Factor Prodomain Differently Modulate Acetylcholine Release in Regenerating and Mature Mouse Motor Synapses
por: Bogacheva, Polina O., et al.
Publicado: (2022)

Differences in the Relative Abundance of ProBDNF and Mature BDNF in A549 and H1299 Human Lung Cancer Cell Media
por: Dorandish, Sadaf, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3umooub5u933cb4ktm1t8ki250